Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $15,102 | 2 | 76.1% |
| Food and Beverage | $3,373 | 119 | 17.0% |
| Current or prospective ownership or investment interest | $1,063 | 1 | 5.4% |
| Education | $304.06 | 22 | 1.5% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| DySIS Medical, Inc. | $15,000 | 1 | $0 (2018) |
| Esaote North America, Inc. | $1,063 | 1 | $0 (2017) |
| Gynesonics, Inc. | $834.98 | 5 | $0 (2021) |
| Myriad Women's Health, Inc. | $375.00 | 1 | $0 (2023) |
| AMAG Pharmaceuticals, Inc. | $287.71 | 21 | $0 (2019) |
| Accelerate Diagnostics Inc. | $207.50 | 1 | $0 (2020) |
| PFIZER INC. | $166.65 | 9 | $0 (2024) |
| Evofem Biosciences, Inc. | $162.30 | 9 | $0 (2024) |
| ABBVIE INC. | $160.46 | 10 | $0 (2022) |
| Astellas Pharma US Inc | $138.90 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $392.49 | 20 | SHIELD THERAPEUTICS INC ($88.74) |
| 2023 | $538.57 | 10 | Myriad Women's Health, Inc. ($375.00) |
| 2022 | $251.83 | 14 | ABBVIE INC. ($62.99) |
| 2021 | $538.60 | 25 | Gynesonics, Inc. ($113.27) |
| 2020 | $933.45 | 16 | Gynesonics, Inc. ($544.95) |
| 2019 | $394.87 | 13 | Gynesonics, Inc. ($176.76) |
| 2018 | $15,379 | 27 | DySIS Medical, Inc. ($15,000) |
| 2017 | $1,413 | 19 | Esaote North America, Inc. ($1,063) |
All Payment Transactions
144 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $21.92 | General |
| Category: Hematology | ||||||
| 12/05/2024 | PFIZER INC. | PREMARIN (Drug), DUAVEE, MYFEMBREE | Food and Beverage | In-kind items and services | $23.40 | General |
| Category: WOMENS HEALTH | ||||||
| 11/26/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $29.41 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/12/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $23.86 | General |
| Category: Hematology | ||||||
| 10/29/2024 | PFIZER INC. | COMIRNATY (Biological), ABRYSVO | Food and Beverage | In-kind items and services | $28.43 | General |
| Category: VACCINES | ||||||
| 08/29/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $19.93 | General |
| Category: Biological | ||||||
| 08/14/2024 | Evofem Biosciences, Inc. | — | Food and Beverage | In-kind items and services | $24.32 | General |
| 08/08/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $19.20 | General |
| Category: Hematology | ||||||
| 06/13/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $18.49 | General |
| Category: Biological | ||||||
| 05/22/2024 | Biogen, Inc. | — | Food and Beverage | In-kind items and services | $24.37 | General |
| 05/16/2024 | PFIZER INC. | PREMARIN (Drug), MYFEMBREE, NURTEC ODT | Food and Beverage | In-kind items and services | $20.12 | General |
| Category: WOMENS HEALTH | ||||||
| 04/30/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: Biological | ||||||
| 04/10/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $23.76 | General |
| Category: Hematology | ||||||
| 03/14/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $18.11 | General |
| Category: Biological | ||||||
| 03/08/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $18.89 | General |
| 03/05/2024 | Evofem Biosciences, Inc. | — | Food and Beverage | In-kind items and services | $21.20 | General |
| 02/29/2024 | Organon Llc | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $12.17 | General |
| Category: ETONOGESTREL | ||||||
| 02/29/2024 | Organon Llc | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $0.45 | General |
| Category: ETONOGESTREL | ||||||
| 02/27/2024 | Hologic Sales and Service, LLC | APTIMA (Device) | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: Diagnostics | ||||||
| 02/01/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $15.26 | General |
| Category: Biological | ||||||
| 12/28/2023 | Myriad Women's Health, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $375.00 | General |
| Category: ONCOLOGY | ||||||
| 12/21/2023 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $20.63 | General |
| Category: HORMONE THERAPY | ||||||
| 12/06/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: Biological | ||||||
| 11/10/2023 | MAYNE PHARMA COMMERCIAL LLC | NEXTSTELLIS (Drug) | Food and Beverage | In-kind items and services | $21.97 | General |
| Category: CONTRACEPTIVE | ||||||
| 09/19/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $12.86 | General |
| Category: Biological | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Improved Practice Outcomes and Value Excellence in Colposcopy | DySIS Medical, Inc. | $15,000 | 1 |
| SONATA | Gynesonics, Inc. | $101.86 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,636 | 2,145 | $434,901 | $175,406 |
| 2022 | 14 | 1,673 | 2,292 | $484,234 | $200,984 |
| 2021 | 15 | 1,707 | 2,282 | $472,582 | $200,995 |
| 2020 | 13 | 1,544 | 1,983 | $311,623 | $136,332 |
All Medicare Procedures & Services
58 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93976 | Ultrasound of abdomen and pelvis artery and vein blood flow | Office | 2023 | 202 | 259 | $78,200 | $35,170 | 45.0% |
| 76830 | Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | Office | 2023 | 203 | 260 | $52,550 | $29,388 | 55.9% |
| 58558 | Biopsy of lining of uterus and/or removal of polyp using an endoscope | Office | 2023 | 15 | 15 | $75,000 | $19,426 | 25.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 147 | 183 | $27,550 | $14,520 | 52.7% |
| 87801 | Detection test by nucleic acid for multiple organisms, amplified probe(s) technique | Office | 2023 | 176 | 211 | $50,640 | $14,517 | 28.7% |
| 87798 | Detection test by nucleic acid for organism, amplified probe technique | Office | 2023 | 176 | 421 | $33,680 | $14,478 | 43.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 90 | 90 | $18,000 | $13,402 | 74.5% |
| 76856 | Complete ultrasound scan of pelvis | Office | 2023 | 86 | 96 | $38,400 | $9,693 | 25.2% |
| 87661 | Detection test by nucleic acid for trichomonas vaginalis (genital parasite), amplified probe technique | Office | 2023 | 176 | 211 | $16,880 | $7,256 | 43.0% |
| 87563 | Detection of mycoplasma genitalium by dna or rna probe | Office | 2023 | 172 | 204 | $16,320 | $7,016 | 43.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 43 | 43 | $6,450 | $4,427 | 68.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 41 | 43 | $6,500 | $2,238 | 34.4% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2023 | 32 | 32 | $2,656 | $1,623 | 61.1% |
| 87625 | Detection test by nucleic acid for human papillomavirus (hpv), types 16 and 18 only | Office | 2023 | 21 | 21 | $6,300 | $834.54 | 13.2% |
| 87624 | Detection test by nucleic acid for human papillomavirus (hpv), high-risk types | Office | 2023 | 21 | 21 | $3,150 | $722.19 | 22.9% |
| 88142 | Pap test, manual screening | Office | 2023 | 35 | 35 | $2,625 | $694.75 | 26.5% |
| 93976 | Ultrasound of abdomen and pelvis artery and vein blood flow | Office | 2022 | 212 | 278 | $83,900 | $39,795 | 47.4% |
| 76830 | Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | Office | 2022 | 211 | 278 | $56,150 | $32,997 | 58.8% |
| 58558 | Biopsy of lining of uterus and/or removal of polyp using an endoscope | Office | 2022 | 17 | 17 | $85,000 | $23,597 | 27.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 156 | 216 | $32,500 | $18,235 | 56.1% |
| 76856 | Complete ultrasound scan of pelvis | Office | 2022 | 130 | 164 | $65,600 | $17,271 | 26.3% |
| 87801 | Detection test by nucleic acid for multiple organisms, amplified probe(s) technique | Office | 2022 | 189 | 238 | $57,120 | $16,496 | 28.9% |
| 87798 | Detection test by nucleic acid for organism, amplified probe technique | Office | 2022 | 189 | 449 | $35,920 | $15,548 | 43.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 84 | 84 | $16,800 | $12,922 | 76.9% |
| 87661 | Detection test by nucleic acid for trichomonas vaginalis (genital parasite), amplified probe technique | Office | 2022 | 188 | 237 | $18,960 | $8,210 | 43.3% |
About Dr. Gregory Shifrin, MD
Dr. Gregory Shifrin, MD is a Specialist healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/21/2007. The National Provider Identifier (NPI) number assigned to this provider is 1477688604.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gregory Shifrin, MD has received a total of $19,842 in payments from pharmaceutical and medical device companies, with $392.49 received in 2024. These payments were reported across 144 transactions from 38 companies. The most common payment nature is "" ($15,102).
As a Medicare-enrolled provider, Shifrin has provided services to 6,560 Medicare beneficiaries, totaling 8,702 services with total Medicare billing of $713,716. Data is available for 4 years (2020–2023), covering 58 distinct procedure/service records.
Practice Information
- Specialty Specialist
- Location Brooklyn, NY
- Active Since 02/21/2007
- Last Updated 07/08/2007
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1477688604
Products in Payments
- DySIS digital colposcope (Device) $15,000
- PROBE,SE3123 EC 8-4 MHZ (Device) $1,063
- Sonata System (Device) $544.95
- MYRISK (Device) $375.00
- INTRAROSA (Drug) $230.35
- ACCELERATE PHENO (Device) $207.50
- Sontata System (Device) $176.76
- RS Harmony Test Related Products (Device) $130.75
- Veozah (Drug) $117.19
- Phexxi (Drug) $116.78
- SONATA SONOGRAPHY-GUIDED TRANSCERVICAL FIBROID ABLATION SYSTEM (Device) $113.27
- INJECTAFER (Drug) $105.94
- LO LOESTRIN FE (Drug) $102.96
- ACCRUFER (Drug) $88.74
- PREMARIN (Drug) $85.63
- MYFEMBREE (Drug) $70.02
- Global Endometrial Abiation (Device) $68.07
- ANNOVERA (Drug) $60.61
- novasure advanced (Device) $60.00
- DILAPAN-S (Device) $50.70
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Brooklyn
Idan Sharon, M.d, M.D
Specialist — Payments: $2.3M
Dr. Sean Studer, M.d, M.D
Specialist — Payments: $411,591
Dr. Michael Lewis, M.d, M.D
Specialist — Payments: $68,268
Dr. Marc Avram, Md, MD
Specialist — Payments: $48,018
Michael Amoashiy, Md, MD
Specialist — Payments: $41,408
Dr. Madhavi Reddy, M.d, M.D
Specialist — Payments: $40,649